跳至主要内容
临床试验/JPRN-UMIN000047043
JPRN-UMIN000047043招募中未知

eutralizing antibody titer after COVID-19 vaccination in Japanese elderly population - Neutralizing antibody titer after COVID-19 vaccination in Japanese elderly population

Medical Corporation, Forkmore0 个研究点目标入组 181 人开始时间: 2022年3月1日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
181

研究概览

简要总结

The geometric means of the first neutralizing antibody titer (NAT: AU/ml) were 645[49-8745] in OLD group (>= 65: N=119) and 1777 [159-19821] in YOUNG Group (< 65: N=62) respectively. The proportion of subjects (>=1280 AU/ml) were 39/119(32.8%) vs 39/62(62.9%) in the first measurement and 0/16(0.0%) vs 3/16(18.8%) in the second. Negative test results (<50) were 7/119(3.9%) vs (6/62(5.0%) vs 1/61(0.2%)) in the first NAT and (3/16(4.8%) vs 0/13(0.0%) in the second.

研究设计

研究类型
Observational

入排标准

年龄范围
12years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • No signature of informed consent

研究者

发起方
Medical Corporation, Forkmore

相似试验